NO911041L - Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika. - Google Patents

Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.

Info

Publication number
NO911041L
NO911041L NO91911041A NO911041A NO911041L NO 911041 L NO911041 L NO 911041L NO 91911041 A NO91911041 A NO 91911041A NO 911041 A NO911041 A NO 911041A NO 911041 L NO911041 L NO 911041L
Authority
NO
Norway
Prior art keywords
preparation
tetrazolyltyomethyl
procedure
cephalosporin antibiotics
cephalosporin
Prior art date
Application number
NO91911041A
Other languages
English (en)
Norwegian (no)
Other versions
NO911041D0 (no
Inventor
Frederick Henri Jung
Original Assignee
Ici Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Pharma filed Critical Ici Pharma
Publication of NO911041D0 publication Critical patent/NO911041D0/no
Publication of NO911041L publication Critical patent/NO911041L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
NO91911041A 1990-03-16 1991-03-15 Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika. NO911041L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90400724 1990-03-16

Publications (2)

Publication Number Publication Date
NO911041D0 NO911041D0 (no) 1991-03-15
NO911041L true NO911041L (no) 1991-09-17

Family

ID=8205690

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911041A NO911041L (no) 1990-03-16 1991-03-15 Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.

Country Status (16)

Country Link
US (1) US5200404A (de)
EP (1) EP0447118B1 (de)
JP (1) JPH05247058A (de)
KR (1) KR910016762A (de)
AT (1) ATE131484T1 (de)
AU (1) AU638556B2 (de)
CA (1) CA2038411A1 (de)
DE (1) DE69115313T2 (de)
FI (1) FI911286L (de)
GB (1) GB9104238D0 (de)
IE (1) IE910711A1 (de)
IL (1) IL97439A0 (de)
NO (1) NO911041L (de)
NZ (1) NZ237351A (de)
PT (1) PT97044A (de)
ZA (1) ZA911657B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
JPH11124384A (ja) * 1997-10-17 1999-05-11 Otsuka Chem Co Ltd 3−セフェム化合物の製造法
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
BRPI0817101A2 (pt) 2007-09-14 2017-05-09 Addex Pharmaceuticals Sa 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
SI2203439T1 (sl) 2007-09-14 2011-05-31 Ortho Mcneil Janssen Pharm 1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
ES2401691T3 (es) 2008-11-28 2013-04-23 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Derivados de indol y de benzoxacina como moduladores de los receptores metabotrópicos de glutamato
ES2440001T3 (es) 2009-05-12 2014-01-27 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-A]piridina y su uso para el tratamiento o prevención de trastornos neurológicos y psiquiátricos
SG176018A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2552455T3 (es) 2010-11-08 2015-11-30 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
CA2814998C (en) 2010-11-08 2019-10-29 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
US10537573B2 (en) 2014-01-21 2020-01-21 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
IL279202B2 (en) 2014-01-21 2023-09-01 Janssen Pharmaceutica Nv Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926957A (en) * 1971-01-29 1975-12-16 Glaxo Lab Ltd Penicillin antibiotics
US4024134A (en) * 1971-01-29 1977-05-17 Glaxo Laboratories Limited Syn isomers of cephalosporins having α-hydroximino- or α-acyloxyiminoacylamido groups at position-7
GB1433141A (en) * 1972-07-07 1976-04-22 Glaxo Lab Ltd Antibiotics
US3991046A (en) * 1972-07-07 1976-11-09 Glaxo Laboratories Limited Penicillin antibiotics
US4493833A (en) * 1976-04-12 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
EP0272827A3 (de) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-Heterocyclethiomethyl-cephalosporine

Also Published As

Publication number Publication date
JPH05247058A (ja) 1993-09-24
NZ237351A (en) 1992-12-23
AU7263991A (en) 1991-09-19
FI911286A7 (fi) 1991-09-17
DE69115313T2 (de) 1996-05-02
AU638556B2 (en) 1993-07-01
NO911041D0 (no) 1991-03-15
EP0447118B1 (de) 1995-12-13
EP0447118A2 (de) 1991-09-18
CA2038411A1 (en) 1991-09-17
EP0447118A3 (en) 1992-06-03
US5200404A (en) 1993-04-06
ATE131484T1 (de) 1995-12-15
GB9104238D0 (en) 1991-04-17
FI911286L (fi) 1991-09-17
ZA911657B (en) 1991-11-27
FI911286A0 (fi) 1991-03-15
DE69115313D1 (de) 1996-01-25
PT97044A (pt) 1991-10-31
IL97439A0 (en) 1992-06-21
IE910711A1 (en) 1991-09-25
KR910016762A (ko) 1991-11-05

Similar Documents

Publication Publication Date Title
NO911041L (no) Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.
NO943093L (no) Fremgangsmåte for fremstilling av clavulansyre
NO996108L (no) 9-oksinerytromycinderivater
NO975901L (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
AU614204B2 (en) 16-hydroxymethyl amphotericin b derivatives
EP0453574A4 (en) Cephalosporin derivative
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
CA2120229A1 (fr) Derives de methylpiperazinoazepine, leur preparation et leur utilisation
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
CA2179634A1 (en) 4-arylisoindole analgesics
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
NO890287D0 (no) Fremstilling av beta-laktam-antibiotika.
WO1987003590A1 (fr) Medicament pour le traitement des maladies du foie
GR3004095T3 (de)
GB9323404D0 (en) Pharmaceuticals
AU7719491A (en) Therapeutic compound
WO1996027378A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9323403D0 (en) Pharmaceuticals
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
JO1229B1 (en) Penicillin derivatives
AU5932394A (en) New compound, leustroducsin H, its preparation and its therapeutic use
GR3020519T3 (en) Polar cephalosporin derivatives and process for their preparation